Short Glenn Frank
SEC insider (Form 3/4/5 filer). CIK 0002049070. Chief Scientific Officer at AtaiBeckley Inc. (ATAI) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Sep 11, 2026. Located in NEW YORK, NY.
Companies Short Glenn Frank has filed insider reports for
- AtaiBeckley Inc. (ATAI): Officer, Chief Scientific Officer
- ATAI Life Sciences N.V. (ATAI): Officer, Chief Scientific Officer
Short Glenn Frank
CIK: 0002049070
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (16.7%)
Position reduction
Option Exercises (M)1 (16.7%)
Derivative conversions
Awards (A)3 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (16.7%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Sep 11, 2026ATAI
AtaiBeckley Inc.
DispositionDirect42.3K shares- - Jan 30, 2026ATAI
AtaiBeckley Inc.
AwardDirectStock Option
675K shares- - Jan 30, 2026ATAI
AtaiBeckley Inc.
AwardDirectRestricted Stock Units
150K shares- - Mar 21, 2025ATAI
ATAI Life Sciences N.V.
SaleDirect13.2K shares at avg. $1.35$18K - Mar 14, 2025ATAI
ATAI Life Sciences N.V.
ExerciseDirect32.5K shares- - Mar 3, 2025ATAI
ATAI Life Sciences N.V.
AwardDirectStock Option
757.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 11, 2026 |  ATAI AtaiBeckley Inc. | Disposition | 42,333 | - | $0 | Direct |
| Jan 30, 2026 | ATAI AtaiBeckley Inc. | Award Stock Option | 675,000 | - | - | Direct |
| Jan 30, 2026 | ATAI AtaiBeckley Inc. | Award Restricted Stock Units | 150,000 | - | - | Direct |
| Mar 21, 2025 | ATAI ATAI Life Sciences N.V. | Sale | 13,161 | $1.35 | $17,767 | Direct |
| Mar 14, 2025 | ATAI ATAI Life Sciences N.V. | Exercise | 32,500 | - | - | Direct |
| Mar 3, 2025 | ATAI ATAI Life Sciences N.V. | Award Stock Option | 757,915 | - | - | Direct |
1-6 of 6 transactions